Ireland
--:--IST
Starting soon Observational

Illness Perception and Treatment Expectations in Lateral Elbow Pain

NCT07722845 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-07-31
Last updated
2026-07-23

Condition(s) studied

Lateral Elbow PainLateral EpicondylitisTennis ElbowChronic Musculoskeletal PainTendinopathy

Study summary

This cross-sectional, correlational study aims to determine the predictors of illness perception and treatment expectations in adults with chronic lateral elbow pain. Sociodemographic characteristics, clinical findings (pain intensity, pain duration, elbow-specific function) and psychosocial variables (pain self-efficacy, fear-avoidance beliefs, pain catastrophizing) will be examined as candidate predictors of two patient-centred constructs: illness perception, measured with the Brief Illness Perception Questionnaire, and treatment expectation, measured with the Treatment Expectation Questionnaire. Data will be analysed using hierarchical multiple linear regression in three predictor blocks. The study is reported according to the STROBE statement.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Aged 18 years or older * Diagnosis of lateral epicondylalgia or lateral elbow pain made by an orthopaedic surgeon or physiatrist * Pain intensity of at least 4 on the Numeric Rating Scale * Pain duration of at least 12 weeks (chronic) * Willing to provide written informed consent Exclusion Criteria: * History of any surgical procedure of the upper extremity * Cervical spine pathology * Inflammatory arthritis affecting the wrist or finger joints (e.g. rheumatoid arthritis) * Active neurological disease or radiculopathy radiating to the upper extremity * Diagnosis of fibromyalgia or another widespread pain syndrome * Currently receiving active psychiatric treatment (e.g. psychosis, severe depression) * Pregnancy * Visual or cognitive impairment of a degree that would prevent completion of the questionnaires

Primary outcome measure(s)

  • Illness perception (Brief Illness Perception Questionnaire, B-IPQ) — Single assessment at enrollment (Day 1)
    The B-IPQ is a 9-item self-report instrument assessing cognitive and emotional representations of illness. Eight items are rated on a 0 to 10 numeric scale covering consequences, timeline, personal control, treatment control, identity, concern, coherence and emotional representation; the ninth item is open-ended and asks about perceived causes. The total score ranges from 0 to 80, with higher scores indicating a more threatening perception of the illness.
  • Treatment expectation (Treatment Expectation Questionnaire, TEX-Q) — Single assessment at enrollment (Day 1)
    The TEX-Q assesses expectations of an upcoming treatment. Fifteen scored items are rated on an 11-point scale from 0 (no expectation at all) to 10 (expecting complete recovery from treatment); six additional items are not included in scoring. Higher scores indicate higher treatment expectation.

Trial sites (1)

FacilityCityRegionStatus
Dr. Fzt. Fatih Celik Ozel Saglik Birimi Istanbul Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07722845 on ClinicalTrials.gov ↗ ← All trials in Turkey